ABOUT AVANTOR
Your partner for customized solutions.
Avantor’s flexible and responsive bioprocessing solutions help you quickly move biologics from research to reality. We collaborate at every step in scaling up your monoclonal antibodies (mAbs) production — maximizing productivity, mitigating risk and reducing waste to accelerate your process.
Global cGMP manufacturing capabilities and a comprehensive supply network avoid critical delays.
Avantor’s channel brand, VWR, provides an integrated, seamless purchasing experience. Access our own trusted brands, as well as an assortment of other leading brands, for a broader selection of media components, animal sera, buffers, process biochemicals, excipients and fluid handling technologies.
Our focus on quality sets science in motion to create a better world.
Customers rely on our structured, integrated quality management system and validated processes to overcome regulatory bottlenecks and supply chain risks. Trust the Avantor experts to develop agile, customized solutions that overcome complex challenges and meet speed-to-market demands.
FEATURED ARTICLES
-
Explore the role of excipients, buffers, and single-use technologies in optimizing high-concentration monoclonal antibody therapies while maintaining patient safety and product quality.
-
Explore how, when, and why pre-use post sterilization integrity testing (PUPSIT) should be used and how to navigate the complexities of filter integrity testing.
-
Review the importance of collaboration and innovation in addressing the challenges with scaling up gene therapy production, from adopting new cell lines to integrating AI in process optimization.
-
Discover the key strategies to overcome, aided by comprehensive support from suppliers, to streamline the formulation and fill-finish process and deliver effective mAb therapies on time.
-
Single-use technologies are an integral and rapidly growing part of the bioprocessing manufacturing landscape. Take a look at trends in single-use, plus top tips for making the switch.
-
Explore how early adoption of fully compendial, cGMP raw materials can provide a return on investment by reducing steps in your process and potential yield losses and avoiding lost production time.
-
To ensure patient safety — as well as a portable process outside of Europe — it’s time to find a novel reagent without harmful, endocrine-disrupting properties.
-
This article addresses key advancements at each step in the production of viral vectors — from maximizing titer output at scale upstream to optimized formulation compositions at fill/finish — to support commercial scale.
-
Learn about a ready-to-use, custom buffer solution provided to a biopharmaceutical manufacturing facility in order to help them reduce costs and the amount of time spent on QC testing and validation.
-
A consultative partnership brought valuable solutions to a global CDMO that was experiencing performance issues with their fetal bovine serum, and needed a new product source of superior quality fast.
-
Explore the customized, multi-component solution designed to meet quality and packaging specifications, while including an animal-origin element, as well as a non-compendial component.
-
Learn about the services that helped four companies ramp up their mAb production despite complications when it comes to hydration and buffer prep.
-
Learn more about an effective, biodegradable solution for the viral inactivation process that controls protein impurities and is compatible with downstream unit operations.
-
Custom buffer solutions produced for a multinational biopharmaceutical company, enabled a fast facility expansion while still meeting the customers strict quality and regulatory requirements.
-
To meet the speed to market demands of today requires process standardization and portability, improvements in raw material supply and sourcing and greater supply chain control.
-
What are four of best practices for single-use supply chain management and how can you avoid the worst-case scenario of being dependent upon an unreliable or small supply chain?
-
The use of AI and machine learning tools can begin the process of moving from predictive, human-driven inventory management and manufacturing processes to genuine, data-driven decision making
-
Recent research in the fast-growing market of monoclonal antibodies (mAbs) identifies excipients that reduce viscosity of high-concentration formulation and improve stability across a wide concentration range.
-
A study was conducted to evaluate the resin performance for a leading medical technology company needed a better purification process solution.
-
Review a Protein A resin solution assisting biotech companies who are working with and removing impurities from a wide variety of antibodies.
-
In response to the growing demand for monoclonal antibodies, researchers are looking at different areas of the downstream process where they can improve efficiency and scalability.
-
Improve your mAb production by adopting a technology platform approach using a fluid handling system that can transition from development to your final production volume.
-
Using cGMP grade reagents earlier makes for a seamless transition while maintaining quality and viability.
-
Learn more about an integrated monoclonal antibody (mAb) downstream purification process that enables significant throughput improvement while removing critical impurities.
-
Understanding the alternative buffer management and preparation strategies available can ensure you have the tools and resources to remain competitive in today’s growing bioprocessing industry.
-
A GMP-compliant, novel process sampling solution for taking multiple conical tube samples at varying time points results in immediate process efficiency and sterility assurance.
-
Biopharma manufacturers can benefit by adopting a global single-use supply chain strategy early in the drug development life cycle and carefully evaluating their single-use equipment and materials suppliers.
CONTACT INFORMATION
Avantor
One Radnor Corporate Center, Building One, Suite 200, 100 Matsonford Road
Radnor, PA 19087
UNITED STATES
Phone: 1 610 386 1700
AVANTOR PRODUCTS
- J.T.Baker® Cell Lysis Solution And J.T.Baker® Endonuclease
- Process Chromatography Resins And Media
- Recombinant Protein A Chromatography Columns And Resins
- Chemicals And Excipients For Biopharmaceutical Production
- Buffer Management Manufacturing Solutions For Biopharma Workflows
- Connect Single-Use Solutions To Next Gen Therapies
- Custom Masterflex Single-Use Bioprocess Assemblies
- Inline Buffer Dilution System
- Masterflex® Peristaltic Pump And Fluid Handling Solutions
- J.T.Baker® Viral Inactivation Solution
BROCHURES
- Enhance Lysis Performance And Minimize Process Challenges
- Standard And Customized Single-Use Solutions
- Peristaltic Pumps And Fluid Handling Solutions
- Custom Hydration Management: Buffers, Reagents And Cell Culture Media
- Solutions For Monoclonal Antibody Manufacturing
- Avantor Downstream Optimization Services
VIDEOS
-
Save time and money by reducing steps when introducing chemicals and excipients into your process with direct dispense packaging system.
-
Flexible and responsive scale up is more critical than ever before. A reliable partner can navigate the challenges in the face of supply chain uncertainty.
WEBINARS
-
Explore research on a biodegradable cell lysis solution paired with a quality endonuclease, offering improved particle protection during agitation, reduced foaming and viscosity, and room-temperature storage and shipping.
-
Need to change your viral inactivation method due to environmental concerns? Don’t underestimate how long it will take to change your process.
-
What are the four new-edge production technologies that better remove impurities, reduce aggregation and improve stability
-
Join experts for an an in-depth look at novel techniques to reduce process and hold steps, downstream process innovations and more, backed by study results.